Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and Entyvio

Clinical trial NCT06732804 · COMPLETED

Trial details

NCT number: NCT06732804
Sponsor: Alvotech Swiss AG
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Male and Female Subjects

Start date: 2025-02-11
Primary completion: 2026-01-08
Enrollment: 385

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.